Fibrox
Latest round
- Angel
Last raised
- Jul 2024
Total raised
- Undisclosed
Investors
- 3
About Fibrox
Established in 2021 and based in Shanghai, China, FibroX operates as a biotechnology company dedicated to providing innovative cell therapy products for intervertebral disc. The CEO of the company, Ming Fan has experience in marketing and product development in the orthopaedic industry., Ltd. and Yongkan Investment. The company mainly provides cell therapy products and solutions for patients with degenerative disc disease (DDD). The DDD includes cervical spondylosis, intervertebral disc herniation, lumbar spinal stenosis and other diseases. Its core product is FibroCell human fibroblast injection, which is targeted at patients with early and mid-stage intervertebral disc degeneration. FibroCell human fibroblast injection has completed IIT clinical studies in multiple dose groups. FibroX also provides FibroCellTM allogeneic fibroblast injection, which is a fibroblast therapy for the treatment of intervertebral disc degeneration. The company generates revenue by providing cell therapy products and solutions for patients with degenerative disc disease, such as FibroCell human fibroblast injection and FibroCellTM allogeneic fibroblast injection.
Who invested in Fibrox
3 investors across 1 round
See all investors in Fibrox
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jul 12, 2024
Amount
Undisclosed
Investors
Questions about Fibrox
Who invested in Fibrox?
Fibrox has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Fibrox raised?
Fibrox has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Fibrox last raise money?
Fibrox's most recent round on record is a Angel, in Jul 2024.
What does Fibrox do?
Established in 2021 and based in Shanghai, China, FibroX operates as a biotechnology company dedicated to providing innovative cell therapy products for intervertebral disc.
Where is Fibrox headquartered?
Fibrox is headquartered in Shanghai, China.
Which VCs invest in companies like Fibrox?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Fibrox's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Fibrox? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.